{"public_metrics": {"retweet_count": 32, "reply_count": 2, "like_count": 47, "quote_count": 5}, "source": "Twitter Web App", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "conversation_id": "1279125932091904000", "id": "1279281511456370688", "text": "@JamesTodaroMD New Lancet study:  \"Patients with rheumatic disease who were taking hydroxychloroquine had a\nlower risk of COVID-19 infection than patients taking other disease-modifying anti-rheumatic drugs (OR 0\u00b709\n[95% CI 0\u00b701\u20130\u00b794]; p=0\u00b7044).\"\nhttps://t.co/je6HTn3JSZ", "reply_settings": "everyone", "possibly_sensitive": false, "entities": {"mentions": [{"start": 0, "end": 14, "username": "JamesTodaroMD", "id": "803788403179474945"}], "urls": [{"start": 247, "end": 270, "url": "https://t.co/je6HTn3JSZ", "expanded_url": "https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30227-7/fulltext", "display_url": "thelancet.com/journals/lanrh\u2026"}]}, "referenced_tweets": [{"type": "replied_to", "id": "1279125932091904000"}], "in_reply_to_user_id": "803788403179474945", "created_at": "2020-07-04T05:10:54.000Z", "lang": "en", "author_id": "816468081119674369"}